Literature DB >> 19258947

Clinicopathologic characteristics of malignant germ cell tumors in the ovaries of Korean women: a Korean Gynecologic Oncology Group Study.

Ki Heon Lee1, In Ho Lee, Byoung Gie Kim, Joo Hyun Nam, Won Kyu Kim, Soon Beom Kang, Sang Young Ryu, Chi Heum Cho, Ho Sun Choi, Kyung Tai Kim.   

Abstract

From January 1995 to December 2000, medical records of 196 patients were collected from 14 hospitals nationwide and were reviewed retrospectively. We evaluated the clinicopathologic characteristics of malignant germ cell tumors in the ovaries of South Korean women and determined the prognostic factors affecting recurrence. The mean patient age was 23.8 years (range, 4-63 years), and the median follow-up period was 67 months (range, 1-128 months). The distribution of the International Federation of Gynecology and Obstetrics stage was as follows: 128 cases (65.3%) in stage I, 27 cases (13.8%) in stage II, 39 cases (19.9%) in stage III, and 2 cases (1.0%) in stage IV. Histologically, immature teratoma was the most common tumor type (n = 68), followed by dysgerminoma (n = 54), endodermal sinus tumor (n = 38), mixed form (n = 24), and choriocarcinoma (n = 12). A fertility-sparing operation was performed in 134 patients, staging operation in 43 patients, and hysterectomy and bilateral salpingo-oophorectomy in 19 patients. Postoperative chemotherapy was administered in 166 patients, and the most common regimen was bleomycin, etoposide, and cisplatin (n = 120). Recurrence was observed in 13 patients (6.8%) and was influenced by the stage of the tumor and patient age (>40 years). The 5-year survival rate was 96.7%. During the follow-up period, 20 patients had 22 pregnancies that resulted in 17 normal deliveries at term and 5 abortions. The results of this study demonstrate that most malignant germ cell tumors of the ovary in Korean women are detected in the early stage and have excellent survival outcomes with conservative operation and platinum-based chemotherapy.

Entities:  

Mesh:

Year:  2009        PMID: 19258947     DOI: 10.1111/IGC.0b013e31819914c5

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  6 in total

Review 1.  Current Strategy for the Treatment of Ovarian Germ Cell Tumors: Role of Extensive Surgery.

Authors:  Jin Li; Xiaohua Wu
Journal:  Curr Treat Options Oncol       Date:  2016-08

2.  A rare case of postmenopausal immature teratoma with a recurrent grave course.

Authors:  Ali Babacan; Yasar Kemal Akpak; Cem Kizilaslan; Ismet Gun; Ercument Mungen; Vedat Atay
Journal:  Int J Clin Exp Med       Date:  2014-04-15

3.  Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution.

Authors:  Chung Won Lee; Min Jong Song; Sung Taek Park; Eun Young Ki; Sung Jong Lee; Keun Ho Lee; Ki Sung Ryu; Jong Sup Park; Soo Young Hur
Journal:  World J Surg Oncol       Date:  2011-10-11       Impact factor: 2.754

4.  Pseudopapillary and Macrofollicular Microscopic Growth Patterns in an Advanced Stage Ovarian Dysgerminoma: A Case Report.

Authors:  Fatemeh Nili; Niusha Nobari; Alireza Abdollahi
Journal:  Iran J Pathol       Date:  2018

5.  Malignant Mixed Germ Cell Tumors of the Ovary: A Series of Rare Cases.

Authors:  Lajya Devi Goyal; Balpreet Kaur; Rama Kumari Badyal
Journal:  J Reprod Infertil       Date:  2019 Oct-Dec

6.  Nomograms to predict the prognosis in malignant ovarian germ cell tumors: a large cohort study.

Authors:  Zixuan Song; Yizi Wang; Yangzi Zhou; Dandan Zhang
Journal:  BMC Cancer       Date:  2022-03-10       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.